| Mankind Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543904 |
NSE Symbol : MANKIND |
P/E(TTM) : 51.96 |
|
ISIN Demat : INE634S01028 |
Div & Yield% : - |
EPS(TTM) : 46.79 |
|
Book Value(₹) : 240.21 |
Market Cap(₹Cr) : 97,396.59 |
Face Value(₹) : 1.00 |
| Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 40.06 | 40.06 | 40.06 | 40.06 | 40.06 |
| Reserves | 9,583.75 | 7,743.85 | 6,500.39 | 4,694.21 | 3,611.39 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Shareholders Funds | 9,623.81 | 7,783.91 | 6,540.45 | 4,734.27 | 3,651.45 |
| Secured Loans | 0.00 | 0.00 | 623.66 | 95.00 | 0.00 |
| Unsecured Loans | 8.56 | 4.69 | 64.23 | 5.85 | 2.56 |
| Total Debt | 8.56 | 4.69 | 687.89 | 100.85 | 2.56 |
| Other Liabilities | 123.00 | 109.04 | 89.02 | 62.92 | 61.33 |
| Total Liabilities | 9,755.37 | 7,897.64 | 7,317.36 | 4,898.04 | 3,715.34 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 4,342.32 | 3,775.59 | 3,292.31 | 1,227.09 | 1,116.92 |
| Less: Accumulated Depreciation | 937.98 | 633.37 | 365.62 | 239.68 | 172.16 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 3,404.34 | 3,142.22 | 2,926.69 | 987.41 | 944.76 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 187.58 | 494.78 | 386.57 | 165.57 | 147.62 |
| Investments | 4,430.13 | 3,102.23 | 2,525.87 | 2,396.89 | 1,783.67 |
| Current Assets, Loans & Advances | |||||
| Inventories | 1,075.59 | 1,032.22 | 1,266.69 | 826.91 | 533.48 |
| Sundry Debtors | 749.47 | 492.64 | 470.59 | 369.17 | 418.62 |
| Cash and Bank Balance | 761.01 | 155.15 | 138.85 | 476.95 | 197.95 |
| Loans and Advances | 664.84 | 775.44 | 1,070.80 | 520.92 | 404.39 |
| Total Current Assets | 3,250.91 | 2,455.45 | 2,946.92 | 2,193.95 | 1,554.43 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 1,175.55 | 1,080.01 | 1,319.07 | 789.20 | 589.96 |
| Provisions | 415.20 | 337.61 | 266.74 | 193.08 | 225.80 |
| Total CL & Provisions | 1,590.75 | 1,417.62 | 1,585.81 | 982.28 | 815.76 |
| Net Current Assets | 1,660.16 | 1,037.83 | 1,361.11 | 1,211.66 | 738.67 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 347.44 | 263.37 | 165.26 | 122.49 | 105.72 |
| Deferred Tax Liability | 419.03 | 319.23 | 200.79 | 109.45 | 84.67 |
| Net Deferred Tax | -71.59 | -55.86 | -35.53 | 13.04 | 21.05 |
| Other Assets | 144.76 | 176.45 | 152.67 | 123.47 | 79.56 |
| Total Assets | 9,755.38 | 7,897.65 | 7,317.37 | 4,898.04 | 3,715.34 |
| Contingent Liabilities | 261.93 | 78.72 | 135.24 | 15.79 | 0.00 |